Lower risk of mortality and suicide with antipsychotic LA injections vs. oral agents Study finds decreased all-cause mortality and suicide risk with long-acting (LA) injectable antipsychotics compared to oral agents in newly diagnosed schizophrenia. Amazon Prime intros prescription savings benefit Kamylle Frenette: paralympian and pharmacy student Spotlight 3: Dr. Google’s blessings It has been said that if people's work is taken away from them, they start to fish for problems and create them—and society pays the price. This week's pharmacy phunny Techs in N.B. permitted to administer injections Meet the 2021 Pharmacy U Innovation Award winners AstraZeneca pause major challenge for Ontario pharmacists, but they're ready for big mRNA rollout: Bates These latest developments will likely raise questions in patients’ minds about when they can and should be getting their second doses. Patients prefer buprenorphine SC depot over daily SL doses for opioid dependence Study examines patient-reported outcomes for opioid dependence treatment with weekly or monthly subcutaneous depot buprenorphine versus daily sublingual buprenorphine. Doctors, advocates cry foul over stalled action on pharmacare First Previous 362 363 364 365 366 Next Last
